35 results
PRE 14A
BVS
Bioventus Inc - Ordinary Shares
10 Apr 24
Preliminary proxy
4:08pm
markets and his extensive expertise in accelerating innovation, driving operational excellence, enhancing go-to-market strategies, and driving … of the Biotechnology Innovation Organization, a membership and advocacy organization focused on improving biotech research and applying biotech innovations
8-K
BVS
Bioventus Inc - Ordinary Shares
21 Dec 23
Bioventus Names Robert Claypoole as President and Chief Executive Officer
8:00am
innovation, driving organizational efficiencies, and enhancing go-to-market strategies.
In connection with his appointment, on December 19, 2023
8-K
EX-10.1
BVS
Bioventus Inc - Ordinary Shares
21 Dec 23
Bioventus Names Robert Claypoole as President and Chief Executive Officer
8:00am
) any invention, innovation, manufacturing process, trade secret, design, idea or improvement related, directly or indirectly, to Bioventus’ business
8-K
EX-99.1
jog0p9tvpqxx20
21 Dec 23
Bioventus Names Robert Claypoole as President and Chief Executive Officer
8:00am
8-K/A
EX-10.1
pzrqd4faswjw q5fu
11 Apr 23
Departure of Directors or Certain Officers
5:17pm
8-K/A
EX-99.1
k0xl0e dz
27 Sep 22
2021 Consolidated Financial Statements
4:03pm
DEF 14A
x5fabvv
29 Apr 22
Definitive proxy
12:00am
8-K
EX-10.1
e9q6leiy90rz8cxa1
28 Feb 22
Departure of Directors or Certain Officers
4:05pm
8-K
pnz88ailz iewk
27 Dec 21
Departure of Directors or Certain Officers
9:01am
S-8
EX-99.1
xd1v5mtmuul9y6
29 Oct 21
Registration of securities for employees
4:51pm
8-K
EX-99.1
lhuim8f 8pxfud0
26 Oct 21
Bioventus and Misonix Stockholders Approve the Acquisition of Misonix by Bioventus
5:24pm
424B3
pjrpl0uz
24 Sep 21
Prospectus supplement
9:30am
S-4/A
yj9z9ah 1s0g1b
22 Sep 21
Registration of securities issued in business combination transactions (amended)
8:35am
S-4
qu1x85rp1c
8 Sep 21
Registration of securities issued in business combination transactions
5:22pm